Trial Identifier: | D7860C00001 |
Sponsor: | AstraZeneca |
NCTID:: | NCT05662033 |
Start Date: | December 2022 |
Primary Completion Date: | October 2024 |
Study Completion Date: | October 2024 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
GB | Harrow, GB, HA1 3UJ |
GB | Wythenshawe, GB, M23 9QZ |